Vpriv 54092-0701
Generic: Velaglucerase Alfa
Product NDC
54092-0701- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 26, 2010
- Listing Expires
- December 31, 2026
- Application
- BLA022575
Need to source Vpriv? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Velaglucerase Alfa | 2.5 mg/mL |
Drug Class
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
Packaging Options(1)
1 VIAL, GLASS in 1 BOX (54092-701-04) / 4 mL in 1 VIAL, GLASS